Ultimo aggiornamento: agosto 17, 2026

Course Agenda

Computer Validation General Overview

  • Computer Validation fundamentals a walk-through of a complete validation of a small example system
  • Who needs to validate?
  • Cos'è la convalida informatica?
    • Core principles
    • Brief history of computer validation
  • Why is validation necessary and what regulations guide validation requirements?
  • Review of the computer validation references in regulations and guidances:
    • 21 CFR parte 211
    • 21 CFR parte 810
    • 21 CFR parte 11
    • Allegato 11: Computerized Systems
    • Guidance: Q7A GMPs for Active Pharmaceutical Ingredients
    • Guidance: Principi generali di validazione del software
    • Guidance: Sistemi computerizzati utilizzati nelle indagini cliniche
  • When and how are systems validated?
  • Review of key FDA Warning Letters related to computer validation

Computer Validation Process and Deliverables

  • What is the SDLC (System Development Life Cycle) processo?
  • How does computer validation fit into the SDLC?
  • What content must be covered?
  • What are the expected tasks and deliverables?
  • System/software specifications
  • Requirements options and documentation
  • Come 21 CFR parte 11 applies to computer validation
  • Design Qualification (DQ) and vendor selection
  • Risk Assessment in computer validation
    • Where does it apply?
    • A walkthrough of the GAMP risk assessment process
  • Validation Plans and Master Validation Plans
  • Installation Qualification (QI)
    • The five topics expected in IQ documents
  • Operational Qualification (OQ) and Performance Qualification (PQ)
    • Testing strategies and level of detail
    • How much testing is enough?
    • Examples of effective test cases and system errors discovered
  • SOPs required for system operation and maintenance
    • How they related to FDA Warning Letters
  • Validation Summary Reportse

 

Overview of 21 CFR parte 11 (Parte 11)

  • Background and purpose of Part 11
  • Overview of Part 11 (review regulation)
  • Review of the Part 11 implications in regulations and guidances:
    • 21 CFR parte 58 GLP
    • 21 CFR parte 211 GMP
    • 21 CFR parte 312 GCP (IND)
    • 21 CFR parte 810 QSR
    • Guidance: Parte 11 scope and application (settembre 2003)
    • Guidance: Sistemi computerizzati utilizzati nelle indagini cliniche
    • Guide to the Inspection of Pharmaceutical Laboratories
  • Review of Part 11-related FDA Warning Letters
  • Discussion of example systems and the evaluation of Part 11 Compliance decisions
  • Industry trends and approaches the future of Part 11 issues
  • Interactive discussion of Part 11 issues and concerns (bring your questions)
  • Achieving and Maintaining Part 11 Conformità

GAMP-Specific Computer Validation Topics

  • The industry guidance for Good Automated Manufacturing Practice (SPORT)
  • How GAMP addresses the FDA’s expectations for computer validation
  • SPORT 5 versus GAMP 4
  • How to transition to GAMP 5 from GAMP 4
  • A review of the supplementary GAMP guidances and where they apply

Auditing Computer Systems

  • Auditing GxP computer systems
  • Auditing suppliers of computer systems for GxP use
  • Auditing developers for customized systems
  • The general process for auditing computer systems
  • Variations that can save time and money
  • Review of an example audit checklist
  • Primary areas of focus (what to look for)
  • Examples of audit findings

 

 

Revisione scientifica di casi

Revisione scientifica del caso

Ti piacerebbe capire se i programmi clinici sono attuali, recenti sviluppi della ricerca, o potrebbero esserlo gli approcci emergenti rilevante per la tua situazione individuale?

Invia la tua domanda al nostro team scientifico. La sede centrale di NBScience nel Regno Unito coordina le richieste attraverso la rete internazionale di centri medici, scienziati, e consulenti specializzati.

  • Revisione delle informazioni fornite
  • Informazioni rilevanti sulla ricerca e sul programma clinico
  • Una risposta chiara focalizzata sulla tua situazione
Cosa succede dopo? Invia la tua domanda, ricevere una revisione scientifica mirata, e ottieni una risposta chiara sulla ricerca e sui programmi clinici rilevanti per la tua situazione.
La tua revisione scientifica sarà preparata da Dott. Helen Melnik,Dottorato di ricerca , chi ha più di 25 anni di esperienza nella ricerca sulle cellule staminali e nei programmi clinici internazionali.

Nessun obbligo. La tua domanda verrà esaminata in modo confidenziale.

Solo informazioni didattiche e di ricerca. Questo servizio no costituiscono un parere medico, diagnosi, prescrizione, o uno personalizzato raccomandazione terapeutica.


NBScienza

organizzazione di ricerca a contratto

Whatsapp